Related Experiment Video
Updated: Jun 19, 2025
07:17
Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
Published on: August 23, 2024
1.1K
A-to-I Editing Is Subtype-Specific in Non-Hodgkin Lymphomas
Cai Chen1,2, Ralf Bundschuh1,2,3,4,5
1Biophysics Graduate Program, The Ohio State University, Columbus, OH 43210, USA.
Genes
|July 27, 2024
Summary
Adenosine-to-inosine (A-to-I) RNA editing is implicated in cancer. This study reveals distinct RNA editing patterns in Non-Hodgkin lymphomas (NHLs), differentiating them from normal tissues and among subtypes.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Cancer involves genetic and epigenetic alterations.
- Adenosine-to-inosine (A-to-I) RNA editing is an emerging factor in tumorigenesis.
Purpose of the Study:
- To systematically investigate transcriptome-wide A-to-I RNA editing events in Non-Hodgkin lymphomas (NHLs).
- To identify differentially edited sites between NHL subtypes and normal samples.
- To explore the correlation between RNA editing and gene expression in NHL.
Main Methods:
- Utilized a computational pipeline to analyze A-to-I editing sites.
- Compared editing levels between NHL and normal tissue samples.
- Examined genome-wide RNA editing profiles across different NHL subtypes.
Main Results:
- Identified numerous differentially edited sites in NHL compared to normal samples.
- Most differentially edited sites were found in non-coding regions.
- Demonstrated that RNA editing profiles can distinguish NHL from normal tissues and even NHL subtypes.
Conclusions:
- Establishes a significant link between A-to-I RNA editing and Non-Hodgkin lymphomas.
- Suggests RNA editing plays a role in aberrant gene regulation in NHL.
- Highlights RNA editing as a potential biomarker for NHL classification.
